Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
PRA Health Sciences, Inc. (PRAH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/01/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Disposed/sold 34,500 shares
@ $0 Disposed/sold 37,500 options to buy
@ $101.42, valued at
$3.8M
Disposed/sold 16,666 options to buy
@ $95.94, valued at
$1.6M
Disposed/sold 17,114 options to buy
@ $103.3, valued at
$1.8M
Disposed/sold 5,647 restricted stock units
@ $0 Disposed/sold 14,008 restricted stock units
@ $0 |
|
07/01/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Disposed/sold 46,500 shares
@ $0 Disposed/sold 39,000 options to buy
@ $75.81, valued at
$3M
Disposed/sold 45,000 options to buy
@ $102.44, valued at
$4.6M
Disposed/sold 62,000 options to buy
@ $95.94, valued at
$5.9M
Disposed/sold 63,560 options to buy
@ $103.3, valued at
$6.6M
Disposed/sold 20,974 restricted stock units
@ $0 Disposed/sold 4,000 restricted stock units
@ $0 Disposed/sold 52,030 restricted stock units
@ $0 |
|
07/01/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Disposed/sold 4,480 shares
@ $0 Disposed/sold 6,000 options to buy
@ $75.81, valued at
$454.9k
Disposed/sold 20,000 options to buy
@ $81.61, valued at
$1.6M
Disposed/sold 16,666 options to buy
@ $95.94, valued at
$1.6M
Disposed/sold 17,114 options to buy
@ $103.3, valued at
$1.8M
Disposed/sold 5,647 restricted stock units
@ $0 Disposed/sold 2,000 restricted stock units
@ $0 Disposed/sold 14,008 restricted stock units
@ $0 |
|
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Dickinson Alexander George (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Disposed/sold 5,407 shares
@ $0 |
|
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 1,300 shares
@ $167.4, valued at
$217.6k
Sold 13,391 shares
@ $168.06, valued at
$2.3M
Sold 12,114 shares
@ $169.41, valued at
$2.1M
Sold 692 shares
@ $169.75, valued at
$117.5k
Exercised 4,213 options to buy
@ $95.94, valued at
$404.2k
Exercised 18,958 options to buy
@ $101.42, valued at
$1.9M
Exercised 4,326 options to buy
@ $103.3, valued at
$446.9k
|
|
06/21/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 200 shares
@ $166.7, valued at
$33.3k
Sold 24,389 shares
@ $168.17, valued at
$4.1M
Sold 22,587 shares
@ $169.05, valued at
$3.8M
Sold 5,375 shares
@ $169.67, valued at
$912k
Exercised 35,661 options to buy
@ $81.61, valued at
$2.9M
Exercised 8,334 options to buy
@ $95.94, valued at
$799.6k
Exercised 8,556 options to buy
@ $103.3, valued at
$883.8k
|
|
06/21/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 920 shares
@ $166.89, valued at
$153.5k
Sold 161,352 shares
@ $168.13, valued at
$27.1M
Sold 220,195 shares
@ $169, valued at
$37.2M
Sold 59,774 shares
@ $169.63, valued at
$10.1M
Exercised 77,425 options to buy
@ $11.73, valued at
$908.2k
Exercised 166,036 options to buy
@ $11.73, valued at
$1.9M
Exercised 91,000 options to buy
@ $75.81, valued at
$6.9M
Exercised 31,000 options to buy
@ $95.94, valued at
$3M
Exercised 45,000 options to buy
@ $102.44, valued at
$4.6M
Exercised 31,780 options to buy
@ $103.3, valued at
$3.3M
|
|
06/17/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 14,386 shares
@ $168.27, valued at
$2.4M
Sold 202 shares
@ $168.83, valued at
$34.1k
Sold 13,778 shares
@ $166.48, valued at
$2.3M
Sold 500 shares
@ $167.49, valued at
$83.7k
Exercised 8,698 options to buy
@ $101.42, valued at
$882.2k
Exercised 1,933 options to buy
@ $95.94, valued at
$185.5k
Exercised 1,984 options to buy
@ $103.3, valued at
$204.9k
Exercised 9,844 options to buy
@ $101.42, valued at
$998.4k
Exercised 2,188 options to buy
@ $95.94, valued at
$209.9k
Exercised 2,246 options to buy
@ $103.3, valued at
$232k
|
|
06/17/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 30,279 shares
@ $168.27, valued at
$5.1M
Sold 847 shares
@ $168.8, valued at
$143k
Sold 16,316 shares
@ $166.41, valued at
$2.7M
Sold 900 shares
@ $167.49, valued at
$150.7k
Exercised 14,000 options to buy
@ $75.81, valued at
$1.1M
Exercised 7,123 options to buy
@ $81.61, valued at
$581.3k
Exercised 17,216 options to buy
@ $81.61, valued at
$1.4M
|
|
06/17/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 142,093 shares
@ $168.3, valued at
$23.9M
Sold 1,210 shares
@ $168.75, valued at
$204.2k
Sold 83,941 shares
@ $166.44, valued at
$14M
Sold 4,104 shares
@ $167.49, valued at
$687.4k
Exercised 132,986 options to buy
@ $11.73, valued at
$1.6M
Exercised 16,242 options to buy
@ $11.73, valued at
$190.5k
Exercised 71,803 options to buy
@ $11.73, valued at
$842.2k
|
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 14,486 shares
@ $0 Sold 4,659 shares
@ $170.45, valued at
$794.1k
Sold 1,811 shares
@ $170.45, valued at
$308.7k
Exercised 10,486 restricted stock units
@ $0 Exercised 4,000 restricted stock units
@ $0 Granted 52,030 restricted stock units
@ $0 |
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 4,823 shares
@ $0 Sold 1,278 shares
@ $170.45, valued at
$217.8k
Sold 906 shares
@ $170.45, valued at
$154.4k
Exercised 2,823 restricted stock units
@ $0 Exercised 2,000 restricted stock units
@ $0 Granted 14,008 restricted stock units
@ $0 |
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 2,823 shares
@ $0 Sold 850 shares
@ $170.45, valued at
$144.9k
Exercised 2,823 restricted stock units
@ $0 Granted 14,008 restricted stock units
@ $0 |
|
06/03/2021 |
4
| Dickinson Alexander George (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 250 shares
@ $0 |
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/28/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 2,048 shares
@ $166.77, valued at
$341.5k
|
|
01/11/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 3,136 shares
@ $130.04, valued at
$407.8k
|
|
12/18/2020 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 33,372 shares
@ $120.12, valued at
$4M
Exercised 13 options to buy
@ $11.73, valued at
$148.2 Exercised 20,736 options to buy
@ $11.73, valued at
$243.2k
|
|
09/16/2020 |
4
| Stettin Glen D. (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 799 shares
@ $0 |
|
08/17/2020 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Sold 6,073 shares
@ $102.88, valued at
$624.8k
|
|
08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2020 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 31,460 restricted stock units
@ $0 Granted 8,000 restricted stock units
@ $0 Granted 95,340 options to buy
@ $103.3, valued at
$9.8M
|
|
06/03/2020 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 8,470 restricted stock units
@ $0 Granted 4,000 restricted stock units
@ $0 Granted 25,670 options to buy
@ $103.3, valued at
$2.7M
|
|
06/03/2020 |
4
| Gaenzle Christopher L (EVP, Chf Admin Ofcr & Gen Coun) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 8,470 restricted stock units
@ $0 Granted 25,670 options to buy
@ $103.3, valued at
$2.7M
|
|
|
|
|